Shareholder Class Action

     Shareholders claim Vertex Pharmaceuticals inflated its share price by failing to disclose adverse information about its experimental hepatitis C drug, VX-950 (telaprevir), in Boston Federal Court.

     Shareholders accuse directors of Candela Corp. or wasting corporate assets and breaching fiduciary duties, in Middlesex County Court, Woburn, Mass.
     Shareholders accuse Familymedsgroup of wasting more than $80 million in corporate assets, in Hartford Superior Court.

Exit mobile version